TITLE

Quebec doubling PET capacity

AUTHOR(S)
Pindera, Loreen
PUB. DATE
June 2005
SOURCE
CMAJ: Canadian Medical Association Journal;6/21/2005, Vol. 172 Issue 13, p1671
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Loreen Pindera is a journalist with CBC Radio in Montreal.
ACCESSION #
17290897

 

Related Articles

  • The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma. Hoppe, B. S.; Moskowitz, C. H.; Zhang, Z.; Maragulia, J. C.; Rice, R. D.; Reiner, A. S.; Hamlin, P. A.; Zelenetz, A. D.; Yahalom, J. // Bone Marrow Transplantation;Jun2009, Vol. 43 Issue 12, p941 

    We examined the role of fluorodeoxyglucose-positron emission tomography (FDG-PET) and the addition of involved field radiotherapy (IFRT) as potential modifiers of salvage therapy. From January 2000 to June 2007, 83 patients with chemosensitive relapsed or primary refractory diffuse large B-cell...

  • Imaging of adrenocortical metastases with [11C]metomidate. Mitterhauser, Markus; Dobrozemsky, Georg; Zettinig, Georg; Wadsak, Wolfgang; Vierhapper, Heinrich; Dudczak, Robert; Kletter, Kurt // European Journal of Nuclear Medicine & Molecular Imaging;Aug2006, Vol. 33 Issue 8, p974 

    The article reports on imaging of adrenocortical metastases with the 11 β-hydroxylase inhibitor [11C]metomidate. It presents a positron emission tomography images taken from a 50-year-old patient with metastatic adrenocortical carcinoma. The interpretation of the findings are presented.

  • Use of FDG-PET Imaging for Patients with Disseminated Cancer of the Appendix. ROHANI, PAYAM; SCOTTI, STEPHEN D.; SHEN, PERRY; STEWART, JOHN H.; RUSSELL, GREGORY B.; CROMER, MARY; LEVINE, EDWARD A. // American Surgeon;Dec2010, Vol. 76 Issue 12, p1338 

    The goal of this study is to evaluate the use of positron emission tomography (PET) in evaluation of patients with peritoneal dissemination of carcinoma of appendiceal origin (PDA). Thirty-three patients with PDA, who had preoperative PET or PET/CT imaging, were analyzed. Using operative,...

  • Saving Lives and Dollars. Schuman, Ilyse // Imaging Economics;Apr2009, Vol. 22 Issue 3, p42 

    The author highlights on the benefits of imaging in medicine through cost savings, productivity of workers and patient care. She cites a study using the National Oncologic position emission tomography (PET) Registry data which found that the acquired knowledge of physicians through PET scans...

  • Hybrid versus fusion imaging: are we moving forward judiciously? Giovanella, Luca; Lucignani, Giovanni // European Journal of Nuclear Medicine & Molecular Imaging;May2010, Vol. 37 Issue 5, p973 

    In this article the author discusses the development of biomedical imaging technologies. The author provides an overview on how hybrid instrument such as positron emission tomography was developed. The author also notes that while the biomedical imaging techniques in oncology is used, its cost...

  • Extending the diagnostic yield of PET imaging. Dallessio, Kathleen M. // Applied Radiology;Nov2004, Vol. 33 Issue 11, Special Section p7 

    Focuses on the use of positron-emission tomography (PET) in medical imaging. Factor that contributed to the increase in PET imaging studies in the U.S.; Strategies in analyzing PET images of the brain; Uses of atlases and software fused to the PET image; Benefit offered by PET to patients with...

  • The role of SPET and PET in monitoring tumour response to therapy. Giannopoulou, Chariklia // European Journal of Nuclear Medicine & Molecular Imaging;2003, Vol. 30 Issue 8, p1173 

    Positron emission tomography (PET) and single-photon emission tomography (SPET) are cross-sectional, quantitative functional imaging modalities in routine use in oncology for the initial staging of cancer, the assessment of patients with recurrent or residual disease and, more recently, for...

  • Real-time breath-hold triggering of myocardial perfusion imaging with a novel cadmium-zinc-telluride detector gamma camera. Buechel, Ronny R.; Pazhenkottil, Aju P.; Herzog, Bernhard A.; Husmann, Lars; Nkoulou, René N.; Burger, Irene A.; Valenta, Ines; Wyss, Christophe A.; Ghadri, Jelena R.; Kaufmann, Philipp A. // European Journal of Nuclear Medicine & Molecular Imaging;Oct2010, Vol. 37 Issue 10, p1903 

    Purpose: The aim of this study was to assess the ability of real-time breath-hold-triggered myocardial perfusion imaging (MPI) using a novel cadmium-zinc-telluride (CZT) gamma camera to discriminate artefacts from true perfusion defects. Methods: A group of 40 patients underwent a 1-day...

  • A Positron Emission Tomography Study to Assess Binding of Lecozotan, a Novel 5-Hydroxytryptamine-1A Silent Antagonist, to Brain 5-HT1A Receptors in Healthy Young and Elderly Subjects, and in Patients With Alzheimer's Disease. Raje, S.; Patat, A. A.; Parks, V.; Schechter, L.; Plotka, A.; Paul, J.; Langstrom, B. // Clinical Pharmacology & Therapeutics;Jan2008, Vol. 83 Issue 1, p86 

    This positron emission tomography (PET) study was conducted to assess binding of lecozotan, a new potent and silent 5-hydroxytryptamine-1A (5-HT1A) antagonist being developed for the treatment of Alzheimer's disease (AD), to 5-HT1A receptors in the human brain using 11C-labeled WAY-100635....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics